ADA Scientific Sessions 2025 Abstract

Efficacy and Safety of Switching to Iglarlixi from Premix Insulin Regimen in Patients with T2DM—Real-World Experience

By Chun Jui Huang, Shun Jie Yang, Harn-Shen Chen

Study in peopleInterventions

The paper

Chun Jui Huang, Shun Jie Yang, Harn-Shen Chen

Taipei

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 814-P

doi.org/10.2337/db25-814-p

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes